Abhijeet Patra
@patra
Abhijeet Patra
Sign Up | LinkedIn
linkedin.com
Some personal comments and observations on the HHS decision to terminate mRNA grants: | James Timmins
James Timminslinkedin.com
It always blew my mind how much further along we are with DNA and RNA detection compared to proteins. | Evgeny Kiner
Evgeny Kinerlinkedin.com
As an AI partner Andreessen Horowitz, I test dozens of new products a week. | Olivia Moore posted on the topic | LinkedIn
Olivia Moorelinkedin.com
1. On February 24, Extremity Care LLC, a company that sells very expensive bandages made from placentas, donated $5 MILLION TO TRUMP'S SUPER PAC
Days later, Trump froze a pending rule that would BAR MEDICARE FROM COVERING EXTREMITY CARE'S PRODUCTS, which are overpriced & not backed by science.
Things that cost to much because of insurance
Have found pretty good Deep Research results with this prompt. Good for getting up to speed on a new company. Sharing in case it’s helpful.
——
“You are an equity research analyst. Produce a rigorous, source-backed investment memo on {Company} [{Ticker}] with a clear Buy, Hold, or Sell call.
... See more
BuccoCapital Blokex.com
Topo1-based ADCs are broadly seen as superior to MMAE-based ADCs but apparently not for every target or indication.
2 papers out last week showing comparable efficacy in gastric cancer for two different topo1 CLDN18.2 ADCs in "biomarker positive" patients but efficacy is relatively modest at the go forward doses.
___LINE... See more